We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+11.31%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$4.9B
AUM Growth
+$648M
Cap. Flow
+$175M
Cap. Flow %
3.56%
Top 10 Hldgs %
64.34%
Holding
723
New
120
Increased
350
Reduced
164
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 5%
2 Financials 3.65%
3 Healthcare 2.18%
4 Communication Services 1.59%
5 Consumer Discretionary 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
126
State Street SPDR S&P Biotech ETF
XBI
$9.99B
$2.42M 0.05%
27,066
CMCSA icon
127
Comcast
CMCSA
$87.8B
$2.4M 0.05%
54,734
+8,620
+19% +$369K
UPS icon
128
United Parcel Service
UPS
$91.5B
$2.38M 0.05%
15,164
+48
+0.3% +$7.26K
ZTS icon
129
Zoetis
ZTS
$31.2B
$2.38M 0.05%
12,040
+2,138
+22% +$378K
VOT icon
130
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
$2.37M 0.05%
10,796
GL icon
131
Globe Life
GL
$14.3B
$2.26M 0.05%
18,598
-512
-3% -$60.2K
PFF icon
132
iShares Preferred and Income Securities ETF
PFF
$13.3B
$2.25M 0.05%
72,210
+59,530
+469% +$1.78M
LIN icon
133
Linde
LIN
$226B
$2.25M 0.05%
5,471
+349
+7% +$138K
BIV icon
134
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$2.25M 0.05%
29,418
-445
-1% -$32.6K
DIS icon
135
Walt Disney
DIS
$177B
$2.17M 0.04%
24,053
-685
-3% -$60.4K
NVO
136
Novo Nordisk
NVO
$197B
$2.16M 0.04%
20,887
+3,409
+20% +$337K
IBM icon
137
IBM
IBM
$222B
$2.12M 0.04%
12,986
+160
+1% +$24.2K
VSS icon
138
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
$2.11M 0.04%
18,314
-2,374
-11% -$255K
CI icon
139
Cigna
CI
$71.5B
$2.08M 0.04%
6,950
+1,740
+33% +$508K
SYK icon
140
Stryker
SYK
$129B
$2.05M 0.04%
6,858
+1,070
+18% +$300K
TJX icon
141
TJX Companies
TJX
$177B
$2.04M 0.04%
21,757
+929
+4% +$83.3K
LIT icon
142
Global X Lithium & Battery Tech ETF
LIT
$1.57B
$2.03M 0.04%
39,800
APD icon
143
Air Products & Chemicals
APD
$65.7B
$2.02M 0.04%
7,363
+25
+0.3% +$6.87K
LOW icon
144
Lowe's Companies
LOW
$123B
$1.98M 0.04%
8,896
-1,289
-13% -$261K
IGIB icon
145
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$1.96M 0.04%
37,603
+3,545
+10% +$175K
ASML icon
146
ASML
ASML
$645B
$1.93M 0.04%
2,555
+394
+18% +$260K
CSX icon
147
CSX Corp
CSX
$94.7B
$1.91M 0.04%
55,226
+11,209
+25% +$357K
SPGI icon
148
S&P Global
SPGI
$121B
$1.89M 0.04%
4,297
+358
+9% +$141K
VRTX icon
149
Vertex Pharmaceuticals
VRTX
$123B
$1.86M 0.04%
4,569
+201
+5% +$74.3K
VZ icon
150
Verizon
VZ
$193B
$1.84M 0.04%
48,852
+28,473
+140% +$1.01M

Similar funds

Ballentine Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Ballentine Partners held 723 positions worth $4.9B, up 15% from $4.25B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Ballentine Partners deployed $175M of net new capital in Q4 2023, opening 120 new positions and adding to 350 existing holdings. Its largest new stake was First Mid Bancshares: 1,879,711 shares worth $65.2M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $5.31M trimmed.

  • Ballentine Partners's largest Q4 2023 buy was First Mid Bancshares: 1,879,711 shares worth $65.2M.
  • Ballentine Partners added most to Vanguard Morningstar Total Stock Market ETF in Q4 2023, an estimated $14.6M increase.
  • Ballentine Partners's biggest Q4 2023 reduction was Vanguard Total Bond Market, cutting an estimated $5.31M.
  • Ballentine Partners fully exited Schwab US Large- Cap ETF in Q4 2023, selling an estimated $1.89M.
  • Ballentine Partners's ten largest holdings make up 64% of its $4.9B portfolio in Q4 2023.
  • Ballentine Partners opened 120 new positions and closed 41 in Q4 2023.
  • Ballentine Partners's portfolio value rose 15% quarter-over-quarter to $4.9B.

Based on Ballentine Partners's 13F filing for Q4 2023, filed 23 Jan 2024.